http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017394571-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea1fff38e27d2aa34504ab65f60e7631
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
filingDate 2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb100f5c7e43920e36a9ee5d02c1d274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e57a7f814dde4a6975e7bb0498571cbb
publicationDate 2019-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2017394571-A1
titleOfInvention Stable liquid composition comprising botulinum toxin
abstract The present disclosure relates to a stable liquid composition comprising a botulinum toxin as an active ingredient which is ready-to-use without the need for a reconstitution process, and particularly, to a liquid composition capable of preventing the botulinum toxin from aggregating even when the botulinum toxin is contained at a low concentration to thereby exhibit high stability, and efficiently preventing adsorption, etc., to a container, to constantly maintain an activity of the botulinum toxin for each batch or for each liquid vial. Specifically, the present disclosure relates to the liquid composition comprising (i) a botulinum toxin as an active ingredient, (ii) L-alanine or methyl cellulose, (iii) a non-ionic surfactant, and (iv) a buffer, and optionally, an isotonic agent. The liquid composition of the botulinum toxin according to the present disclosure is which is ready-to-use without performing a reconstitution process, and thus, it is possible to improve user's convenience, and reduce a deviation of botulinum toxin activity, etc., due to dilution errors in the reconstitution process, etc. Further, the liquid composition according to the present disclosure efficiently prevents the botulinum toxin from aggregating even at a low botulinum toxin concentration to thereby have extremely excellent storage stability, and efficiently prevents adsorption of the botulinum toxin to a container, thereby constantly maintaining an activity of the botulinum toxin for each batch or for each liquid vial.
priorityDate 2017-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11333
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559037
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCW6JHZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27406
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO70695
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27404
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9G059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490256
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP54635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9INJ1
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1491
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD1MEI6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36284
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP89681
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36285
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO72120
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DOK3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71080
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5950

Total number of triples: 52.